Barry Noorda, MD
Obstetrics & Gynecology · Logan, UTNPI 1558351742
Payments from drug & device makers
Across 105 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$311
- Astellas Pharma US Inc$221
- Organon$156
- Hologic Sales And Service, LLC$117
- Channel Medsystems, Inc.$111
- Exeltis, USA Inc.$107
- plus $822 from 23 others
What the payments were for
- Food & beverage$1,846100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $311 |
| Astellas Pharma US Inc | 13 | $221 |
| Organon | 13 | $156 |
| Hologic Sales And Service, LLC | 7 | $117 |
| Channel Medsystems, Inc. | 1 | $111 |
| Exeltis, USA Inc. | 6 | $107 |
| Coopersurgical, Inc. | 6 | $89 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| Evofem Biosciences, Inc. | 4 | $76 |
| Merck | 4 | $68 |
| Johnson & Johnson | 3 | $64 |
| Bayer | 4 | $64 |
| Boston Scientific | 2 | $49 |
| Therapeuticsmd, Inc. | 2 | $43 |
| Conmed Corporation | 2 | $42 |
| Myovant Sciences Inc. | 2 | $38 |
| Aspira Women's Health Inc | 2 | $33 |
| Coloplast | 1 | $19 |
| Roche Diagnostics Corporation | 1 | $18 |
| Biogen | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $15 |
| Si-bone, Inc. | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Sage Therapeutics, LLC | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $13 |
| Meditrina | 1 | $11 |
How this compares
$1,846 in reported general payments places this provider in the 70th percentile of 294 obstetrics & gynecology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate ErZolpidem Tartrate | 14 | $209 |
| Estradiol | 11 | $99 |
| Zolpidem Tartrate | 27 | $97 |
| Rosuvastatin Calcium | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Logan
- Chase PetersenLogan$26K
- David KirkmanLogan$8K
- Nathan BertoldoLogan$4K
- David TurokSalt Lake City$3.4M
- Lori GawronSalt Lake City$2.5M
- Michael TwedeDraper$1.2M
- Alan RappleyeSalt Lake City$805K
- David YoungPleasant Grove$387K
- David BranchSalt Lake City$288K
- Steven JohnsonLayton$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.